» Articles » PMID: 21302063

The Genetics of Teratocarcinoma Transplantation: Tumor Formation in Allogeneic Hosts by the Embryonal Carcinoma Cell Lines F9 and PCC3

Overview
Journal Immunogenetics
Date 2011 Feb 9
PMID 21302063
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Two cultured lines of murine embryonal carcinoma, F9 and PCC3, have been grafted to a variety of allogeneic hosts. The host strains have been classified by their resistance or sensitivity to these carcinomas. Resistance seems to be immunological in nature.Allograft rejection does not correlate withH-2 haplotype, and seems to be controlled by a limited number of recessive factors, presumably histocompatibility genes. We infer that these factors have limited polymorphism in the mouse species. Recombinational analysis of strain A/He has revealed the presence of a recessive factor linked to theH-2 locus. Tumor resistance of strains C57BL/6 and AKR appears to result from the interaction of dominant or semi-dominant factors in theH-2 region with other recessive elements in the genetic background.Though F(1) hybrids between resistant mouse strains and the syngeneic strain 129 are largely tumor-sensitive, a low level of hybrid resistance to F9 has been observed and shown to be eliminated by X-irradiation.

Citing Articles

Susceptibility of allogeneic mice to teratocarcinoma 402AX.

Ostrand-Rosenberg S, Rider T, Twarowski A Immunogenetics. 2012; 10(6):607-12.

PMID: 22457940 DOI: 10.1007/BF01572595.


Semisyngeneic hybrid resistance to murine teratocarcinoma cells.

Bishop G, Dove W Immunogenetics. 2012; 10(4):383-93.

PMID: 22457930 DOI: 10.1007/BF01561588.


Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.

Shedlovsky A, Clipson L, Vandeberg J, Dove W Immunogenetics. 1981; 13(5):413-9.

PMID: 7298086 DOI: 10.1007/BF00346022.


Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles.

Levine A, Teresky A Immunogenetics. 1981; 13(5):405-12.

PMID: 7298085 DOI: 10.1007/BF00346021.


Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses.

Simmler M, Avner P, LEVY J Immunogenetics. 1982; 16(4):349-54.

PMID: 6983494 DOI: 10.1007/BF00372306.


References
1.
Gachelin G, Kemler R, Kelly F, Jacob F . PCC4, a new cell surface antigen common to multipotential embryonal carcinoma cells, spermatozoa, and mouse early embryos. Dev Biol. 1977; 57(1):199-209. DOI: 10.1016/0012-1606(77)90365-7. View

2.
Haldane J, Waddington C . Inbreeding and Linkage. Genetics. 1931; 16(4):357-74. PMC: 1201105. DOI: 10.1093/genetics/16.4.357. View

3.
Artzt K, Jacob F . Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. Transplantation. 1974; 17(6):632-4. DOI: 10.1097/00007890-197406000-00015. View

4.
Staats J . Standardized nomenclature for inbred strains of mice: sixth listing. Cancer Res. 1976; 36(12):4333-77. View

5.
Snell G, Graff R, Cherry M . Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc. Transplantation. 1971; 11(6):525-30. View